- Lobbying
- Lobbying by Visby Medical Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Anne Kierig | Legislative Assistant/Director of Special Projects, Senator Dianne Feinstein; Office Counsel & Legislative Assistant, Senator Richard J. Durbin |
Joshua M. Finestone | Legislative Assistant, Rep. Mike Rogers; Legislative Director, Rep. Tom Graves; Legislative Assistant, Sen. Dean Heller; Senior Legislative Assistant, Sen. Dean Heller; Professional Staff, Senate Committee on Commerce, Science and Transportation |
Loren K. Aho | Senior Legislative Assistant, Rep. Laura Richardson |
Daris D. Meeks | Counsel, Policy Director, & Policy Analyst, House Republican Conference; Legislative Counsel, Representative Hensarling; Counsel to Chairman, Federal Housing Finance Board; Counsel, Senate Banking, Housing, and Urban Affairs Committee Director of Domestic Policy, Office of the Vice President; Deputy Assistant to the President |
Nicholas D. Choate | Deputy Legislative Director, Sen. Claire McCaskill; Legislative and Communications Assistant, Rep. Karen McCarthy; Legislative Assistant/Press Secretary, Rep. Dan Boren; Legislative Director, Rep. Jim Costa; Legislative Director, Rep. Bart Stupak |
Gregory M. Gill | Legislative Director, Representative Hoyer, Asst. Staff, House Appropriations Committee |
Bart Stupak | U.S. Representative, 1993-2011 |
Loren Aho | Senior Legislative Assistant, Rep. Laura Richardson |
Michael Bloomquist | Attorney-Advisor, Department of the Interior Office of the Solicitor; General Counsel, House Committee on Science; Staff Director, Deputy Staff Director, General Counsel, Deputy General Counsel, House Committee on Energy and Commerce General Counsel, Joint Select Committee on Deficit Reduction |
Yardly Pollas-Kimble | Chief of Staff, Deputy Chief of Staff, Legislative Director, Rep. Bobby Rush |
William R. Nordwind | House Telecommunications Subcommittee, Counsel; Representative Upton, Legislative Director, Counsel, Deputy Chief of Staff; Representative Pryce, Legislative Director and Counsel; Representative Upton, Legislative Director and Counsel |
John V. Drzewicki | Deputy chief of staff, Rep. John Katko; Legislative director, Rep. Scott Perry; Senior legislative assistant, Rep. Scott Perry; Legislative assistant, Rep. Steve Austria; Legislative correspondent, Rep. Steve Austria Staff assistant, Rep. Steve Austria; Policy Advisor, US House of Representatives; Policy Director, US House of Representatives |
Rebecca Pearson | n/a |
Jodie Curtis | n/a |
Ilisa Halpern Paul | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Defense - Dept of (DOD)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Defense - Dept of (DOD)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to the industry providing innovative medical testing used to diagnose diseases..
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Pharmacy
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Pharmacy
Registration
Issue(s) they said they’d lobby about: Issues related to the industry providing innovative medical testing used to diagnose diseases..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate